Biochemical premotor biomarkers for Parkinson's disease

被引：28

作者：

Mollenhauer, Brit ^{[1
,2
]}

Zhang, Jing ^{[3
]}

机构：

[1] Paracelsus Elena Klin, D-34128 Kassel, Germany

[2] Univ Gottingen, Kassel, Germany

[3] Univ Washington, Dept Pathol, Seattle, WA 98195 USA

来源：

MOVEMENT DISORDERS | 2012年 / 27卷 / 05期

关键词：

biomarkers; genomics; metabolomics; Parkinson's disease; premotor; proteomics; HUMAN CEREBROSPINAL-FLUID; ALPHA-SYNUCLEIN; GENE-EXPRESSION; URIC-ACID; ALZHEIMER; PROTEIN; URATE; DJ-1; CSF; PROTEOMICS;

D O I：

10.1002/mds.24956

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathologic processes or of pharmacologic responses to a therapeutic intervention. We reviewed the current status of target protein biomarkers (eg, total/oligomeric a-synuclein and DJ-1) in cerebrospinal fluid, as well as on unbiased processes that can be used to discover novel biomarkers. We have also provide ddetails about strategies toward potential populations/models and technologies, including the need for standardized sampling techniques, to pursue the identification of new biochemical markers in the premotor stage of Parkinson's disease in the future. (C) 2012 Movement Disorder Society

引用

页码：644 / 650

页数：7

共 50 条

[41] Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson's Disease
Raghunathan, Rekha
Turajane, Kathleen
Wong, Li Chin
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
[42] Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review)
Krol-Grzymala, Angelika
Sienkiewicz-Szlapka, Edyta
Fiedorowicz, Ewa
Rozmus, Dominika
Cieslinska, Anna
Grzybowski, Andrzej
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
[43] Biomarkers for Cognitive Impairment in Parkinson Disease
Shi, Min
Huber, Bertrand R.
Zhang, Jing
BRAIN PATHOLOGY, 2010, 20 (03) : 660 - 671
[44] Immune-related biomarkers for Parkinson's disease
Abdi, Ilham Y.
Ghanem, Simona S.
El-Agnaf, Omar M.
NEUROBIOLOGY OF DISEASE, 2022, 170
[45] Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease
Prell, Tino
Witte, Otto W.
Grosskreutz, Julian
FRONTIERS IN NEUROLOGY, 2019, 10
[46] Insights on Peripheral Blood Biomarkers for Parkinson's Disease
Li, Yu-Meng
Liu, Jing-Kai
Chen, Zi-Xuan
Deng, Yu-Lin
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2025, 52 (01) : 72 - 87
[47] Cerebrospinal fluid protein biomarkers in Parkinson's disease
Faizan, Mohd
Sachan, Nidhi
Verma, Oyashvi
Sarkar, Alika
Rawat, Neeraj
Singh, Mahendra Pratap
CLINICA CHIMICA ACTA, 2024, 556
[48] Development of Early Diagnosis of Parkinson’s Disease Using Premotor Symptoms and Blood Changes as Biomarkers
Gusev E.I.
Katunina E.A.
Martinov M.Y.
Blokhin V.E.
Kalinkin A.L.
Alesenko A.V.
Nodel M.R.
Malykhina E.A.
Titova N.V.
Katunin D.A.
Shupik M.A.
Gutner U.A.
Maloshitskaya O.A.
Sokolov S.A.
Kucheryanu V.G.
Pavlova E.N.
Ugrumov M.V.
Neuroscience and Behavioral Physiology, 2021, 51 (8) : 1050 - 1058
[49] Premotor Parkinson's disease: Concepts and definitions
Siderowf, Andrew
Lang, Anthony E.
MOVEMENT DISORDERS, 2012, 27 (05) : 608 - 616
[50] Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy
Robinson, Philip A.
EXPERT REVIEW OF PROTEOMICS, 2010, 7 (04) : 565 - 578

← 1 2 3 4 5 →